Home › Atherosclerosis › Florida › Coral Springs
Atherosclerosis clinical trials in Coral Springs, FL
4 studies for Atherosclerosis are looking for participants at sites in and around Coral Springs (within about 30 miles). Open a study to see who can join and how to contact the study team.
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Care Access - Tamarac, Tamarac · 4 mi away
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- South Florida Clinical Research, Margate · 4 mi away
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
RecruitingPhase 2/3
- South Florida Nephrology Group, PA, Coral Springs
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, Margate · 4 mi away
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Houston, TX10 studies
- Boston, MA10 studies
- Washington, DC9 studies
- Hialeah, FL8 studies
- Arlington, VA8 studies
- Orlando, FL8 studies
- Dallas, TX7 studies
- Memphis, TN7 studies
- Miami, FL7 studies
- Durham, NC7 studies
- Las Vegas, NV7 studies
- Los Angeles, CA6 studies
Other studies in Coral Springs
- Non-Small Cell Lung Cancer14 studies
- Metastatic Cancer6 studies
- Cancer (all types)6 studies
- Melanoma5 studies
- Colorectal Cancer5 studies
- Atopic Dermatitis (Eczema)4 studies
- Multiple Myeloma4 studies
- Breast Cancer4 studies
- Overweight4 studies
- Obesity4 studies
- Diabetic Foot4 studies
- Rheumatoid Arthritis4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.